Abbott ramps up Libre 3 production amid shortages
Sep 20, 2024 · MedTech industry news. “Essentially, some patients are seeing delays in their scripts getting filled at certain U.S. retail pharmacies due to a low on-shelf inventory, and while there are likely some minor supply issues causing these script delays, demand also has been very strong as Abbott continues to gain share in the U.S.,” Marcus wrote on Thursday.
Medical Technology News | MedTech Dive
MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, and more.
Medtech companies lay off thousands in 2024, continuing last …
Feb 12, 2024 · The latest announcements continue a top industry trend from 2023.A MedTech Dive analysis of state Worker Adjustment and Retraining Notification databases found that medical device companies announced layoffs for more than 14,000 employees between Jan. 1, 2023, and June 30, 2024.. Last year, Medtronic, Abbott, Boston Scientific and Johnson & Johnson were among a long list of companies that ...
The number of AI medical devices has spiked in the past decade
Oct 9, 2024 · The number of medical devices with artificial intelligence technology has risen sharply in the past decade. The Food and Drug Administration has authorized 950 AI or machine learning-enabled devices as of Aug. 7, 2024, according to the agency’s database. While the FDA authorized the first AI-enabled device in 1995, the number of …
Establishment Labs wins FDA approval for Motiva breast implants
Sep 30, 2024 · Dive Brief: Establishment Labs received Food and Drug Administration approval for its Motiva breast implants for primary and revision breast augmentation.; Motiva is the first new breast implant to receive U.S. premarket approval since 2013, according to Establishment Labs’ Thursday announcement.
The top medtech trends in 2024
Jan 31, 2024 · Several Wall Street analysts also pointed to pulsed field ablation (PFA) as an emerging market to watch this year. Medtronic announced the first Food and Drug Administration approval for a PFA system in December, and Boston Scientific recently said it got the green light for its system, launching what is expected to be a competitive space for the next several years as other top companies join ...
What’s next at Masimo after CEO Kiani’s exit? | MedTech Dive
Sep 30, 2024 · Masimo’s leadership transition brings a two-year boardroom feud to a close, but questions remain about the path forward in the wake of CEO Joe Kiani’s exit.
Thermo Fisher eliminating 160 jobs, closing Massachusetts facility
Nov 15, 2024 · MedTech industry news. Dive Insight: Demand for viral vectors, which are used in the production of cell and gene therapies, outpaced supply in the late 2010s and into the 2020s as more candidates entered clinical development. Thermo Fisher and other contract development and manufacturing organizations responded by investing in production facilities.
Henry Schein to acquire medical supplier Acentus
Nov 21, 2024 · Dive Brief: Henry Schein said Wednesday it had agreed to acquire Acentus, a medical supplier specializing in delivering products to patients’ homes.; Henry Schein, a medical and dental supplies distributor, said the acquisition brings its homecare medical products platform’s annual revenue base to approximately $350 million.
Senseonics receives FDA clearance for one-year CGM
Sep 17, 2024 · Dive Brief: Senseonics and commercial partner Ascensia Diabetes Care received clearance from the Food and Drug Administration for the first implantable glucose sensor that can be worn for one year, doubling the wear time of Senseonics’ current sensor.; The continuous glucose monitor (CGM), called Eversense 365, is implanted just under the skin.